This transcript has been edited for clarity.
Today I am going to discuss a recent paper on intensive blood pressure control in people with type 2 diabetes. This was a big study. It included over 12,000 participants who were older than age 50, and had type 2 diabetes and an increased risk for cardiovascular disease; either they’d had a prior cardiovascular event, had two or more risk factors, or had a reduced estimated glomerular filtration rate (eGFR).
The study was performed in China and it was really done to determine, potentially once and for all, what the target should be in treating patients with type 2 diabetes. The ACCORD trial tried to answer this question, but it didn’t show overall improvement in outcomes with blood pressure reduction, although when they did subset analysis, they did show benefit in certain…